Zydus Lifesciences completes 50:50 JV transaction with Sunshine Healthcare Lanka

In a significant strategic move, Zydus Lifesciences Ltd has secured a 50 percent interest in Zydus Sunshine Lifesciences Pvt Ltd, forging a joint venture with Sunshine Healthcare Lanka Limited. This partnership was concluded on November 11, 2026, following a timeline extension that pushed the original closing date from June 26, 2026, to December 2026.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T4xhX38
via IFTTT

Read More

Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatment

Lupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve access to treatments for retinal and choroidal vascular diseases. The European Commission previously approved RanluspecTM in vial and syringe-filled presentations for medical use. The biosimilar targets conditions such as wet age-related macular degeneration and diabetic macular edema.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fpjaMgs
via IFTTT

Read More

Beyond Business: The Leadership Philosophy of T. Kishan Singh

T. Kishan Singh highlights the influence of his father's dedication on his professional journey in the paper industry. He stresses the role of sustainable practices and customer relationships for long-term business success. Health and fitness are prioritized as essential elements for effective leadership and overall well-being. Singh shares that consistency and resilience are vital in navigating challenges, both personally and professionally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kLsVhBG
via IFTTT

Read More

Deepinder Goyal's $900 Temple wearable faces scrutiny over brain blood-flow claims

Temple, a new wearable device, claims to track blood flow to the brain and other health metrics. Indian doctors express concerns over the validity of these claims, asking for regulatory scrutiny. Some sportspersons promote the device, while critics label it a gimmick without formal medical approvals. Developer Deepinder Goyal states the device is a wellness tracker, not a medical one.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DI9zTA2
via IFTTT

Read More

Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDA

Following an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Voluntary Action Indicated classification. This classification indicates that although objectionable conditions were found in the Telangana manufacturing facility, the absence of immediate regulatory action allows the company to address the issues through voluntary corrective measures.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IXe8H4Z
via IFTTT

Read More

Provisional registration framework proposed for allied healthcare professionals

The National Commission for Allied and Healthcare Professions has proposed a provisional registration framework for eligible professionals, with provisions for bridge courses, supervised clinical training and competency assessments before regular registration. The draft regulations also propose an online registration system and invite public and stakeholder feedback until December 4.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/L2Z4vKU
via IFTTT

Read More

CCI clears Advent International's Rs 3,150 crore investment in Yatharth Hospital

Advent International has officially secured the green light from the Competition Commission of India to channel an impressive Rs 3,150 crore into Yatharth Hospitals through its affiliate, Rasmalai Limited. Post-investment, Advent will own a 24.9 percent minority stake in the healthcare entity, which is poised to leverage this financial boost for its expansion efforts and enhancing its healthcare network amidst a backdrop of thriving operational revenues and profit growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ogpiknU
via IFTTT

Read More